![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 39, 29935-29937, September 29, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Departments of
Received for publication, July 14, 2000
A peptide corresponding to residues 681-690 of
the II-III loop of the skeletal muscle dihydropyridine receptor
Excitation-contraction
(EC)1 coupling in skeletal
and cardiac muscle involves a functional interaction between
dihydropyridine receptors (DHPRs), voltage-gated L-type
calcium channels in the sarcolemma, and ryanodine receptors (RyRs),
calcium release channels in the sarcoplasmic reticulum membrane.
The mechanism of EC coupling differs in skeletal and cardiac muscle. In
cardiac muscle, calcium influx through the pore-forming subunit of the
cardiac DHPR ( An expression plasmid encoding the pore-forming subunit of the
skeletal muscle DHPR ( Primary cultures of myotubes were prepared from newborn dysgenic mice
as described previously (15). Approximately 1 week after plating,
plasmids carrying cDNA for wild-type or mutant DHPRs (0.1-0.2
µg/µl) were microinjected into single nuclei. 36-72 h after
injection, myotubes expressing DHPRs were identified by accumulation of
green fluorescence. Expressing cells bathed in tissue culture medium
(Dulbecco's modified Eagle's medium, Sigma) were examined for
ability to contract in response to electrical stimulation (80-90 V,
10-30 ms). In some cases, 0.5 mM CdCl2 and 0.1 mM LaCl3 were added to the medium to block
Ca2+ influx through DHPRs.
Macroscopic Ca2+ currents and intracellular
Ca2+ transients were measured simultaneously (16) using
borosilicate glass patch pipettes with resistances of 1.5-3.0 M To test the importance of residues 681-690 for DHPR channel
function, for retrograde signaling, and for EC coupling, we constructed a mammalian expression plasmid encoding the full-length pore-forming subunit of the skeletal DHPR ( To assay the ability of
ACCELERATED PUBLICATION
Excitation-Contraction Coupling Is Not Affected by Scrambled
Sequence in Residues 681-690 of the Dihydropyridine Receptor
II-III Loop*
§,
Physiology and ¶ Anatomy
and Neurobiology, College of Veterinary Medicine and Biomedical
Sciences, Colorado State University, Fort Collins, Colorado 80523
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1 subunit (DHPR,
1S) has been
reported to activate the skeletal muscle ryanodine receptor (RyR1)
in vitro. Within this region of
1S, a
cluster of basic residues,
Arg681-Lys685, was previously reported
to be indispensable for the activation of RyR1 in microsomal
preparations and lipid bilayers. We have used an intact
1S subunit with scrambled sequence in this region of the
II-III loop (
1S-scr) to test the importance of residues 681-690 and the basic motif for skeletal-type excitation-contraction (EC) coupling and retrograde signaling in vivo. When
expressed in dysgenic myotubes (which lack endogenous
1S),
1S-scr restored calcium currents
that were indistinguishable, in current density and voltage dependence,
from those restored by wild-type
1S. The scrambled DHPR
also rescued skeletal-type EC coupling, as indicated by electrically
evoked contractions in the presence of 0.5 mM
Cd2+ and 0.1 mM La3+. Furthermore,
the release of intracellular Ca2+, as assayed by the
indicator dye, Fluo-3, had similar kinetics and voltage dependence for
1S and
1S-scr. These data suggest that
residues 681-690 of the
1S II-III loop are not
essential in muscle cells for normal functioning of the DHPR, including skeletal-type EC coupling and retrograde signaling.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1C) activates RyRs (1). However, in
skeletal muscle, EC coupling is independent of the entry of
extracellular Ca2+ (2) and may result instead from a
mechanical coupling between the skeletal DHPR
1 subunit
(
1S) and the skeletal muscle RyR isoform (RyR1).
Expression of
1S/
1C chimeras in dysgenic
myotubes (which lack endogenous
1 subunits) has
established that skeletal-type EC coupling depends upon skeletal
sequence within the putative cytoplasmic region between repeats II and
III (II-III loop, amino acids 666-791 (3)). Chimeric DHPRs in which
smaller segments of the skeletal DHPR were substituted into the cardiac
DHPR subsequently identified residues 720-765 within the II-III loop
as critical for activation of skeletal-type EC coupling (4, 5).
Moreover, this same critical region is essential for "retrograde
signaling," whereby RyR1 enhances the current density of
1S (6). On the other hand, observations in
vitro indicate that a different region of the II-III loop,
residues 671-690 ("peptide A"), is important for activation of
RyR1, as indicated by ryanodine binding, single channel activity, and
calcium release (7-9). Within peptide A, residues 681-690 have been
identified as the "minimum essential region" of the DHPR II-III
loop for activating ryanodine binding and Ca2+ release
(10), and it has been suggested that the integrity of a cluster of five
basic residues (Arg681-Lys685) is requisite
for this region to serve as the physiological trigger for skeletal-type
EC coupling (10, 11). In an attempt to determine whether the specific
sequence of residues 681-690 and the integrity of the cluster of
positively charged residues are required for EC coupling in
vivo, we have constructed a full-length DHPR with a scrambled
sequence in residues 681-690 (
1S-scr). Dysgenic
myotubes expressing
1S or
1S-scr did not
differ in calcium current density, voltage dependence of activation,
electrically evoked contractions, or voltage dependence of
intracellular calcium release. These results indicate that neither the
specific sequence of these residues, nor the integrity of the cluster
of positive charges, is required for skeletal-type EC coupling in
muscle cells.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1S (12)) with scrambled residues
681-690 (
1S-scr) was constructed by overlapping PCR
mutagenesis (13) using
1S as template. This construct is
schematically illustrated in Fig. 1A. The internal forward
and reverse primers encoding the scrambled sequence were
5'-AAGGCCAAGGCCGAGGAGAGGAAAATGAGGTCGAGGGGCAAGCTTCGC-3' and
5'-CTTCTCCTCCTCTCTCTTGTCAGGGCGAAGCTTGCCCCTCGACCTCAT-3'. The mutagenized
product was amplified using the primer pair
5'-GGGTCCTTCTTCATCCTCAACCTGGTGCTGGGC-3' and
5'-GAGGATCTTTACCACGGAGATGGTGCTGGACT-3'. This final PCR product was digested with XhoI and EcoRI and was ligated
into an expression plasmid encoding green fluorescent protein (GFP)
fused to the N terminus of
1S (GFP-
1S
(14)). For this, GFP-
1S was digested with
EcoRI (at nucleotide 1007 in the
1S coding
sequence, generated by a partial digest) and XhoI (at
nucleotide 2653 in the
1S coding sequence). The altered
region of
1S-scr was confirmed by automated DNA sequencing.
when filled with an internal solution containing (in mM) 1 MgCl2, 145 cesium glutamate, 10 HEPES, 2 CsCl, 0.1 EGTA,
and 0.5 K5-Fluo-3 (Molecular Probes, Eugene, OR). The
composition of the bath solution was 10 CaCl2, 145 tetraethylammonium chloride, 0.003 tetrodotoxin, and 10 HEPES (pH 7.4 with tetraethylammonium hydroxide). In some experiments, 0.5 mM CdCl2 and 0.1 mM
LaCl3 were added to the extracellular solution. The voltage
clamp command sequence was to step from a holding potential of
80 mV
to
30 mV for 1 s, to
50 mV for 30 ms, to the test potential
for 200 ms, and back to
80 mV. Test currents were digitally corrected
for linear leakage and capacitive currents. Ca2+ currents
were normalized by linear cell capacitance (pA/pF). All data are
presented as mean ± S.E.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1S) with a scrambled
sequence in this region (
1S-scr, Fig.
1A). Note that the cluster of
charged residues present in the wild-type sequence has been disrupted in
1S-scr. Whole-cell calcium currents recorded from
dysgenic myotubes expressing
1S-scr closely resembled
those recorded from myotubes expressing wild-type
1S
(Fig. 1B) and, like the wild-type currents, were abolished
by application of 0.5 mM Cd2+ and 0.1 mM La3+ (data not shown). Fig. 1C
compares average peak I-V relationships for the two constructs, showing
that they were similar in both voltage dependence and magnitude. Peak
current densities at +40 mV were
5.06 ± 1.12 pA/pF
(n = 14) and
5.11 ± 0.74 pA/pF
(n = 10) for
1S and
1S-scr, respectively.

View larger version (20K):
[in a new window]
Fig. 1.
Scrambled sequence in the DHPR II-III loop
does not alter calcium channel properties of the skeletal muscle
dihydropyridine receptor. A, top, schematic
illustration of the DHPR
1S subunit with the region of
the II-III loop investigated indicated by a bold line.
Bottom, sequence of residues 681-690 in the full-length
1S and
1S-scr constructs used in this
study. B, representative whole-cell calcium currents
recorded from dysgenic myotubes expressing
1S
(left) or
1S-scr (right) in
response to a voltage step to +40 mV. C, neither the average
current density nor the voltage dependence of activation of
1S is altered by scrambled sequence in residues
681-690. Peak current densities for 14 cells expressing
1S (open circles) and 10 cells expressing
1S-scr (filled circles) are
shown.
1S-scr to mediate skeletal-type
EC coupling, dysgenic myotubes expressing either
1S or
1S-scr were tested both for contraction in response to
extracellular stimulation and for depolarization-induced
Ca2+ release. As illustrated in Fig.
2, wild-type
1S restored
evoked contractions in 70% of fluorescent cells tested and
1S-scr restored contractions in 79% of cells tested.
Myotubes expressing either
1S (67%) or
1S-scr (53%) retained the ability to contract even after the addition of 0.5 mM Cd2+ and 0.1 mM La3+ to the bathing medium to block
Ca2+ entry.

View larger version (70K):
[in a new window]
Fig. 2.
Scrambled sequence in the II-III loop does
not prevent the ability of DHPRs to restore EC coupling to dysgenic
myotubes. Dysgenic myotubes expressing either
1S or
1S-scr were bathed in normal medium (gray
bars) or in medium containing 0.5 mM Cd2+
and 0.1 mM La3+ (hatched bars). The
cells were stimulated electrically (10 ms, 90 V), and the percentage
observed to contract is indicated.
As a further test of whether
1S-scr differs from
1S, we measured intracellular Ca2+ release
in voltage-clamped cells by recording changes in fluorescence of the
Ca2+ indicator dye, Fluo-3. In both normal medium and
medium containing Cd2+ and La3+, calcium
transients generated by
1S-scr were similar, in time course and size, to those produced by wild-type
1S (Fig.
3, A-D). The voltage
dependence of calcium release was also similar and for both constructs
showed a sigmoidal response that saturated at strong depolarizations
(Fig. 3E).
|
| |
DISCUSSION |
|---|
|
|
|---|
In this paper we have shown by expression in muscle cells that
wild-type
1S and
1S-scr
(
1S with scrambled sequence in residues 681-690 of the
II-III loop) do not differ in density or voltage dependence of calcium
currents or in skeletal-type EC coupling, as indicated by evoked
contractions in Cd2+/La3+ and by voltage
dependence of intracellular Ca2+ release. Thus, the
function of
1S as a calcium channel and its ability to
participate in EC coupling appear to be unaffected by either the
specific sequence of residues 681-690 or the integrity of a cluster of
basic residues in this region.
The ability of
1S-scr to mediate skeletal-type EC
coupling is consistent with earlier work on
1S/
1C chimeras, which showed that strong
skeletal-type EC coupling occurred when a critical domain of the II-III
loop, residues 720-765, was skeletal in origin (4, 5). The ability of
these chimeras to produce skeletal coupling was independent of whether
there was skeletal or cardiac sequence for residues 681-690. The
interchangeability of cardiac and skeletal sequence in this region
could simply be a consequence of sequence conservation or could mean
that the sequence of these residues is unimportant for skeletal-type EC
coupling. The present results strongly support the latter conclusion.
In vitro studies have shown that RyR1 is activated by a
peptide composed of residues 681-690 (see Fig. 1A; Ref. 10)
or by a slightly larger peptide (peptide A; residues 671-690 (7-9)). This activation is dependent on the integrity of a group of five basic
residues within this region (10, 11). We have now shown that
skeletal-type EC coupling still occurs in muscle cells expressing
1S bearing a scrambled sequence in the peptide A region,
even though the same scrambled sequence abolished the ability of
residues 681-690 to activate RyR1 (10). Thus it seems unlikely that
in vitro activation of RyR1 by peptides implies in
vivo activation of RyR1 by the corresponding region of the II-III
loop. The activation by loop peptides may occur as a consequence of
action at sites inaccessible to the intact II-III loop or may result
from free solution conformations of the peptides that do not occur natively.
In conclusion, it is clear from our results that residues 681-690 are
not required for EC coupling in vivo. However, our results do not exclude the possibility that residues 681-690 play some role in
EC coupling, since moderate decreases in calcium release or efficacy of
EC coupling would be difficult to detect with our methods.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Katherine Parsons and Lindsay Grimes for expert technical assistance.
| |
FOOTNOTES |
|---|
* This work was supported by National Institutes of Health Grant NS24444 (to K. G. B.) with a minority supplement (for C. P.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ Present address: School of Kinesiology, Simon Fraser University, Burnaby, BC V5A 1S6, Canada.
To whom correspondence and reprint requests should be
addressed: Dept. of Anatomy and Neurobiology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523. Tel.: 970-491-5277; Fax: 970-491-7907; E-mail: kbeam@lamar.colostate.edu.
Published, JBC Papers in Press, July 27, 2000, DOI 10.1074/jbc.C000464200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: EC, excitation-contraction; DHPR, dihydropyridine receptor; RyR, ryanodine receptor; GFP, green fluorescent protein; PCR, polymerase chain reaction; F, farad(s).
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Nabauer, M., Callewaert, G., Cleemann, L., and Morad, M. (1989) Science 244, 800-803 |
| 2. | Armstrong, C. M., Bezanilla, F. M., and Horowicz, P. (1972) Biochim. Biophys. Acta. 267, 605-608 |
| 3. | Tanabe, T., Beam, K. G., Adams, B. A., Niidome, T., and Numa, S. (1990) Nature 346, 567-569 |
| 4. | Nakai, J., Tanabe, T., Konno, T., Adams, B., and Beam, K. G. (1998) J. Biol. Chem. 273, 24983-24986 |
| 5. | Grabner, M., Dirksen, R. T., Suda, N., and Beam, K. G. (1999) J. Biol. Chem. 274, 21913-21919 |
| 6. | Nakai, J., Dirksen, R. T., Nguyen, H. T., Pessah, I. N., Beam, K. G., and Allen, P. D. (1996) Nature 380, 72-75 |
| 7. | El-Hayek, R., Antoniu, B., Wang, J., Hamilton, S. L., and Ikemoto, N. (1995) J. Biol. Chem. 270, 22116-22118 |
| 8. | Dulhunty, A. F., Laver, D. R., Gallant, E. M., Casarotto, M. G., Pace, S. M., and Curtis, S. (1999) Biophys. J. 77, 189-203 |
| 9. | Casarotto, M. G., Gibson, F., Pace, S. M., Curtis, S. M., Mulcair, M., and Dulhunty, A. F. (2000) J. Biol. Chem. 275, 11631-11637 |
| 10. | El-Hayek, R., and Ikemoto, N. (1998) Biochemistry 37, 7015-7020 |
| 11. | Zhu, X., Gurrola, G., Jiang, M. T., Walker, J. W., and Valdivia, H. H. (1999) FEBS Lett. 450, 221-226 |
| 12. | Tanabe, T., Takeshima, H., Mikami, A., Flockerzi, V., Takahashi, H., Kangawa, K., Kojima, M., Matsuo, H., Hirose, T., and Numa, S. (1987) Nature 328, 313-318 |
| 13. | Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K., and Pease, L. R. (1989) Gene (Amst.) 77, 51-59 |
| 14. | Grabner, M., Dirksen, R. T., and Beam, K. G. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 1903-1908 |
| 15. | Adams, B. A., and Beam, K. G. (1989) J. Gen. Physiol. 94, 429-444 |
| 16. | Garcia, J., and Beam, K. G. (1994) J. Gen. Physiol. 103, 107-123 |
This article has been cited by other articles:
![]() |
S. Pouvreau, L. Csernoch, B. Allard, J. M. Sabatier, M. De Waard, M. Ronjat, and V. Jacquemond Transient Loss of Voltage Control of Ca2+ Release in the Presence of Maurocalcine in Skeletal Muscle Biophys. J., September 15, 2006; 91(6): 2206 - 2215. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Papadopoulos, V. Leuranguer, R. A. Bannister, and K. G. Beam Mapping Sites of Potential Proximity between the Dihydropyridine Receptor and RyR1 in Muscle Using a Cyan Fluorescent Protein-Yellow Fluorescent Protein Tandem as a Fluorescence Resonance Energy Transfer Probe J. Biol. Chem., October 15, 2004; 279(42): 44046 - 44056. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Dulhunty, S. M. Curtis, S. Watson, L. Cengia, and M. G. Casarotto Multiple Actions of Imperatoxin A on Ryanodine Receptors: INTERACTIONS WITH THE II-III LOOP "A" FRAGMENT J. Biol. Chem., March 19, 2004; 279(12): 11853 - 11862. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Avila, E. H. Lee, C. F. Perez, P. D. Allen, and R. T. Dirksen FKBP12 Binding to RyR1 Modulates Excitation-Contraction Coupling in Mouse Skeletal Myotubes J. Biol. Chem., June 13, 2003; 278(25): 22600 - 22608. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chen, E. Esteve, J.-M. Sabatier, M. Ronjat, M. De Waard, P. D. Allen, and I. N. Pessah Maurocalcine and Peptide A Stabilize Distinct Subconductance States of Ryanodine Receptor Type 1, Revealing a Proportional Gating Mechanism J. Biol. Chem., April 25, 2003; 278(18): 16095 - 16106. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Proenza, J. O'Brien, J. Nakai, S. Mukherjee, P. D. Allen, and K. G. Beam Identification of a Region of RyR1 That Participates in Allosteric Coupling with the alpha 1S (CaV1.1) II-III Loop J. Biol. Chem., February 15, 2002; 277(8): 6530 - 6535. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Ahern, J. Arikkath, P. Vallejo, C. A. Gurnett, P. A. Powers, K. P. Campbell, and R. Coronado Intramembrane charge movements and excitation- contraction coupling expressed by two-domain fragments of the Ca2+ channel PNAS, May 18, 2001; (2001) 111001898. [Abstract] [Full Text] |
||||
![]() |
C. M. Wilkens, N. Kasielke, B. E. Flucher, K. G. Beam, and M. Grabner Excitation-contraction coupling is unaffected by drastic alteration of the sequence surrounding residues L720-L764 of the alpha 1S II-III loop PNAS, April 24, 2001; (2001) 101618098. [Abstract] [Full Text] |
||||
![]() |
T. Yamamoto and N. Ikemoto T-tubule Depolarization-induced Local Events in the Ryanodine Receptor, as Monitored with the Fluorescent Conformational Probe Incorporated by Mediation of Peptide A J. Biol. Chem., January 4, 2002; 277(2): 984 - 992. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamamoto, J. Rodriguez, and N. Ikemoto Ca2+-dependent Dual Functions of Peptide C. THE PEPTIDE CORRESPONDING TO THE Glu724-Pro760 REGION (THE SO-CALLED DETERMINANT OF EXCITATION-CONTRACTION COUPLING) OF THE DIHYDROPYRIDINE RECEPTOR alpha 1 SUBUNIT II-III LOOP J. Biol. Chem., January 4, 2002; 277(2): 993 - 1001. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Wilkens, N. Kasielke, B. E. Flucher, K. G. Beam, and M. Grabner Excitation-contraction coupling is unaffected by drastic alteration of the sequence surrounding residues L720-L764 of the alpha 1S II-III loop PNAS, May 8, 2001; 98(10): 5892 - 5897. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Ahern, J. Arikkath, P. Vallejo, C. A. Gurnett, P. A. Powers, K. P. Campbell, and R. Coronado Intramembrane charge movements and excitation- contraction coupling expressed by two-domain fragments of the Ca2+ channel PNAS, June 5, 2001; 98(12): 6935 - 6940. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |